Showing 501-510 of 1781 results for "".
The Case for Doing the Hard Thing
https://reachmd.com/topics/practice-development/the-case-for-doing-the-hard-thing/49010/Pictorial Eczema Education Shows Promise for Improving Patients’ Quality of Life
https://reachmd.com/programs/dermconsult/pictorial-eczema-education-shows-promise-for-improving-patients-quality-of-life/36438/Management of Poststroke Epilepsy: An Update
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/management-of-poststroke-epilepsy-an-update/32188/Poststroke seizure management is a clinical and research priority to improve prognosis.Tips To Nurture Leads
https://reachmd.com/topics/practice-development/tips-to-nurture-leads/35211/Grow your practice by converting leads to patients.How Do I Advance DE&I in My Practice?
https://reachmd.com/topics/practice-development/how-do-i-advance-dei-in-my-practice/35212/Real Techniques to Promote Diversity and Inclusivity at Your Practice
https://reachmd.com/ma-issues-index/2022-may-june/real-techniques-to-promote-diversity-and-inclusivity-at-your-practice/35168/Addressing diversity requires more than being aware of observable differencesWhat to Know When Hiring a Public Relations Firm
https://reachmd.com/ma-issues-index/september-october-2025/what-to-know-when-hiring-a-public-relations-firm/39269/As the medical landscape evolves, even the most credentialed dermatologists can find themselves overshadowed by trending influencers or competitors who are simply more media-savvy.RSV in Infants and Young Children: Are You Taking It Seriously Enough?
https://reachmd.com/programs/cme/RSV-in-Infants-and-Young-Children-Are-You-Taking-It-Seriously-Enough/39306/Explore RSV prevention strategies in infants, including maternal immunization and monoclonal antibodies, aligned with current AAP guidelines.MS Minute: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/ms-minute-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/32180/MOGAD, an inflammatory demyelinating disease of the central nervous system, has some overlapping clinical features with NMOSD and MS but is a distinct entity with unique pathologic, clinical, and imaging features.Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
https://reachmd.com/programs/project-oncology/oral-contraceptives-and-endometrial-cancer-examining-a-potential-dose-response-protective-effect/35506/As rates of endometrial cancer rise globally, a 2025 meta-analysis offers compelling evidence that oral contraceptives (OCs) could significantly reduce EMC risk. Explore the findings from this new review and its potential implications for the future of patient care.